Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)
NCT00560677 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2021-08-17
Summary
We propose to establish a database characterizing the presence or absence of comorbid PTSD in veterans with schizophrenia or schizoaffective disorder (SAD) receiving services at the Durham VA Medical Center. In addition to the evaluation of PTSD symptoms in veterans with schizophrenia or SAD, this database will facilitate the investigation of a number of additional specific research questions relevant to veterans with psychotic disorders.
Conditions
Sponsors & Collaborators
-
Durham VA Medical Center
lead FED
Principal Investigators
-
Christine E Marx, MD, MA · Durham VAMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research
NCT05870722 ·Status: NOT_YET_RECRUITING
-
Promoting Cognitive Health in Schizophrenia
NCT05661448 ·Status: RECRUITING ·Phase: NA
-
Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia
NCT05498571 ·Status: UNKNOWN
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
NCT00688259 ·Status: COMPLETED ·Phase: NA
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
NCT00546403 ·Status: COMPLETED ·Phase: NA
-
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia
NCT01915017 ·Status: COMPLETED ·Phase: NA
-
5HT3 Antagonism and Auditory Gating in Schizophrenia
NCT00018850 ·Status: COMPLETED ·Phase: NA
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
NCT00373672 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Nicotine on Cognition in Schizophrenia
NCT00383747 ·Status: COMPLETED ·Phase: PHASE4
-
Psychosis-Associated Neuroinflammation in Schizophrenia
NCT02009826 ·Status: COMPLETED
-
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing
NCT04554121 ·Status: COMPLETED ·Phase: NA
-
Patientheque in Patients With a Psychosis .
NCT05340348 ·Status: RECRUITING ·Phase: NA
-
Neurophysiologic Biomarkers for Cognitive Rehabilitation
NCT05945602 ·Status: RECRUITING
-
Trial of Cognitive Behavioral Therapy for Schizophrenia
NCT00300651 ·Status: UNKNOWN ·Phase: PHASE3
-
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
NCT01936220 ·Status: UNKNOWN ·Phase: NA
-
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
NCT00737256 ·Status: UNKNOWN ·Phase: PHASE2
-
Treating Thought Problems in Patients With Schizophrenia
NCT00051740 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
NCT00312949 ·Status: COMPLETED ·Phase: NA
-
The Management of Schizophrenia in Clinical Practice (MOSAIC)
NCT01746134 ·Status: COMPLETED
-
Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
NCT05245539 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
NCT03068806 ·Status: COMPLETED